참고문헌
- Madani SH, Sadeghi E, Rezaee A, et al (2015). Survey of HER2-neu expression in colonic adenocarcinoma in the west of Iran. Asian Pac J Cancer Prev, 16, 7671-4. https://doi.org/10.7314/APJCP.2015.16.17.7671
- Carethers JM (2015). Biomarker-directed targeted therapy in colorectal cancer. J Dig Cancer Rep, 3, 5-10.
- Vecchione L, Jacobs B, Normanno N, et al (2011). EGFR-targeted therapy. Exp Cell Res, 317, 2765-71. https://doi.org/10.1016/j.yexcr.2011.08.021
- Bando H, Yoshino T, Tsuchihara K, et al (2011). KRAS mutations detected by the amplification refractory mutation system-Scorpion assays strongly correlate with therapeutic effect of cetuximab. Br J Cancer, 105, 403-6. https://doi.org/10.1038/bjc.2011.247
- Van Cutsem E, Kohne CH, Hitre E, et al (2009). Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med, 360, 1408-17. https://doi.org/10.1056/NEJMoa0805019
- Dobre M, Dinu DE, Panaitescu E, et al (2015). KRAS gene mutations - prognostic factor in colorectal cancer? Rom J Morphol Embryol, 56, 671-8.
- Perkins G, Pilati C, Blons H, et al (2014). Beyond KRAS status and response to anti-EGFRtherapy in metastatic colorectal cancer. Pharmacogenomics, 15, 1043-52. https://doi.org/10.2217/pgs.14.66
- Rosty C, Young JP, Walsh MD, et al (2013). Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features. Mod Pathol, 26, 825-34. https://doi.org/10.1038/modpathol.2012.240
- Yoon HH, Tougeron D, Shi Q, et al (2014). KRAS codon 12 and13 mutations in relation to disease-free survival in BRAF-wild-type stage III colon cancers from an adjuvant chemotherapy trial (N0147 alliance). Clin Cancer Res,20, 3033-43. https://doi.org/10.1158/1078-0432.CCR-13-3140
- Sameen S, Barbuti R, Milazzo P, et al (2016). Mathematical modeling of drug resistance due to KRAS mutation in colorectal cancer. J Theor Bio, 389, 263-73. https://doi.org/10.1016/j.jtbi.2015.10.019
- Chang YY, Lin JK, Lin TC, et al (2014). Impact of KRAS mutation on outcome of patients with metastatic colorectal cancer. Hepatogastroenterol, 61, 1946-53.
- Dobre M, Comanescu M, Arsene D, et al (2013). K-ras gene mutation status in colorectal cancer: comparative analysis of pyrosequencing and PCR-RFLP. Rom J Morphol Embryol, 54, 567-74.
- Dobre M, Dinu DE, Panaitescu E, et al (2015).KRAS gene mutations - prognostic factor in colorectal cancer? Rom J Morphol Embryol, 56, 671-8.
- Faghani M, FakhriehAsl S, Mansour-Ghanaei F, et al (2012). The Correlation between Microsatellite Instability and the Features of Sporadic Colorectal Cancer in the North Part of Iran. Gastroenterol Res Pract, 2012, 756263.
- Geramizadeh B (2015). Molecular Biomarkers of Colorectal Cancer: A Review of Published Articles From Iran. Ann Colorectal Res, 3, 30100.
- Ansari R, Amjadi H, NorozbeigiN, et al (2007).Survival analysisof colorectal cancer in patients underwent surgical operationin Shariati and Mehr Hospital-Tehran, in a retrospective study. Govaresh, 12, 7-15.
- Naghibalhossaini F, Hosseini HM, Mokarram P, et al (2011). High frequency of genes' promoter methylation, butlack of BRAF V600E Mutation among Iranian colorectal cancerpatients. Pathol Oncol Res, 17, 819-25. https://doi.org/10.1007/s12253-011-9388-5
- Li FH, Shen L, Li ZH, Luo HY, et al (2010).Impact of KRAS mutation and PTEN expression on cetuximab-treated colorectal cancer. World J Gastroenterol, 16, 5881-88. https://doi.org/10.3748/wjg.v16.i46.5881
- Mao C, Zhou J, Yang Z, et al (2012). KRAS, BRAF and PIK3CAmutations and the loss of PTEN expression in Chinese patients with colorectal cancer. PLoS One, 7, 36653. https://doi.org/10.1371/journal.pone.0036653
- Nakanishi R, Harada J, Tuul M, et al (2013).Prognostic relevance of KRASandBRAFmutations in japanese patients with colorectal cancer. Int J ClinOncol, 18, 1042-48.
- Zlobec I, Bihl MP, Schwarb H, et al (2010). Clinicopathological and protein characterization of BRAF-and K-RAS-mutated colorectal cancer and implications for prognosis. Intl J Cancer, 127, 367-80.
- Chaiyapan W, Duangpakdee P, Boonpipattanapong T, et al (2013).Somatic mutations of K-ras and BRAF in Thai colorectal cancer and their prognostic value. Asian Pac J Cancer Prev, 14, 329-32. https://doi.org/10.7314/APJCP.2013.14.1.329